Azacitidine in Pediatric Hematologic Myeloid Malignancies: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-131062
Abstract: Purpose: Hypomethylating agents are approved in adults with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS). By contrast, data in pediatric hematologic malignancies are scarce. Herein, we report the off-label administration of Azacitidine (Aza) in… read more here.
Keywords: azacitidine; treatment; pediatric hematologic; aza ... See more keywords